Heron Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HRTX and other ETFs, options, and stocks.About HRTX
Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034.
CEOCraig A. Collard
CEOCraig A. Collard
Employees122
Employees122
HeadquartersCary, North Carolina
HeadquartersCary, North Carolina
Founded1983
Founded1983
Employees122
Employees122
HRTX Key Statistics
Market cap285.29M
Market cap285.29M
Price-Earnings ratio-34.00
Price-Earnings ratio-34.00
Dividend yield—
Dividend yield—
Average volume3.28M
Average volume3.28M
High today$1.89
High today$1.89
Low today$1.71
Low today$1.71
Open price$1.72
Open price$1.72
Volume1.89M
Volume1.89M
52 Week high$3.93
52 Week high$3.93
52 Week low$1.04
52 Week low$1.04
HRTX News
Simply Wall St 7d
Heron Therapeutics, Inc. Beat Analyst Profit Forecasts, And Analysts Have New EstimatesShareholders might have noticed that Heron Therapeutics, Inc. ( ) filed its quarterly result this time last week. The early response was not positive, with shar...
People also own
Based on the portfolios of people who own HRTX. This list is generated using Robinhood data, and it’s not a recommendation.